Registry Study of CardioFlux Magnetocardiography and Cardiac PET in Adults 40 and Older with Suspected Coronary Ischemia

What this Trial Is About

Researchers are collecting data from patients who undergo standard cardiac PET scans to better understand how the CardioFlux Magnetocardiography MCG device might help detect coronary ischemia. This observational registry includes participants with and without evidence of coronary ischemia on their cardiac PET scans to gather diagnostic information. The study is sponsored by Genetesis Inc. and focuses on patients suspected of myocardial ischemia. Participants will have previously completed a cardiac PET scan within two weeks before joining the study. The CardioFlux device, a magnetocardiography scanner paired with cloud processing software, will be used to record magnetic signals generated by the hearts electrical activity. The study groups include those with negative cardiac PET results and those with positive findings indicating ischemia. During the study, participants will be assessed using their standard cardiac PET data alongside CardioFlux MCG readings. The primary goal is to collect diagnostic data over 24 months to evaluate the potential use of the CardioFlux device in detecting coronary ischemia. Participants will be monitored for their ability to complete the procedure, including lying still for five minutes, and safety considerations related to implanted devices and health conditions are observed.

A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.